Effect of phentolamine and propranolol an alpha and beta receptor blocking agent, on epinephrine and ADP induced platelet factor 3, platelet acid phosphatase availability and platelet factor 4 release.
D000135:Acid Phosphatase / Q000378:metabolism*; D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001779:Blood Coagulation Factors / Q000378:metabolism*; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008074:Lipoproteins / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology*; D010973:Platelet Adhesiveness / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology*
D001779:Blood Coagulation Factors; D008074:Lipoproteins; D000244:Adenosine Diphosphate; D011433:Propranolol; D000135:Acid Phosphatase; D004837:Epinephrine; D010646:Phentolamine